On Friday, November 28, 2025, Eli Lilly and Company (NYSE: LLY) shares traded lower, giving back a slice of recent gains after the drugmaker became the first pharmaceutical company ever to hit a $1 trillion market valuation on November 21.Reuters As of late morning in New York, Lilly stock was changing hands at around $1,075–$1,080 per share, down roughly 2.5% on the day. That still leaves the stock more than 70% above its 52‑week low of $623.78 and only about 3% below its record high of $1,111.99.StockAnalysis Quick snapshot: Eli Lilly stock today (LLY) Based on live data from multiple

Novo Nordisk (NYSE: NVO) shares are trying to stabilise after a bruising November as fresh obesity‑drug data, a higher‑dose Wegovy filing and new analyst calls collide with lingering worries about growth and competition. 1. How Novo Nordisk stock is trading today Novo Nordisk’s U.S.-listed ADRs are changing hands around $49.25, up roughly 1% on the day, after trading between $48.35 and $49.75 in Friday’s session. Intraday volume is a little over 6.7 million shares, in line with recent elevated activity. On its home market in Copenhagen, Novo’s B‑shares closed near 317 DKK, up about 2% on the day but still down roughly 49% year to date, according to MarketScreener data. MarketScreener Even after today’s